Approval · Notice of Compliance 33243 · 2024
TEVA-MODAFINIL: Notice of Compliance 33243
Issued May 16, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33243
- Date
- May 16, 2024
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph (PM) and Package Insert (PI) in alignment with licensor's approved PM and PI. Update the Product Monograph to the Master Template.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-MODAFINIL | Not yet assigned | — |
Medicinal ingredients
- MODAFINIL 100 MG per TAB